Marcato, Paola

6 enregistrements totalisant 3,889,222.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Instituts de recherche en santé du Canada $3,889,222 6 enregistrements

Enregistrements

Marcato, Paola $1,093,950.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
EF 2023-2024
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...

Marcato, Paola $1,090,125.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
EF 2024-2025
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...

Marcato, Paola $918,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
EF 2019-2020
Canada

Support a diverse portfolio of health-related research and knowledge translation projects at any stage, from discovery to application, including commercialization; Promote relevant collaborations acro...

MARCATO, Paola $627,147.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada

The role of ALDH1A3 in breast cancer progression and cancer stem cell biology

Marcato, Paola $100,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2022-2023
Canada

• The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis,...

Marcato, Paola $60,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2017-2018
Canada

Identification of Novel Hypermethylated Tumor Suppressor Genes Important in Breast Cancer Progression and Treatment Response